Mesoblast Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other
companies in this sector in AUSTRALIA :
sales of 35.36 million Australian Dollars [US$27.24 million]
of which 89%
was Clinical Trials),
Idt Australia Limited.
(14.17 million Australian Dollars [US$10.92 million]
Clinuvel Pharmaceuticals Limited
(33.13 million Australian Dollars [US$25.52 million]
of which 100%
Sales levels dropped significantly in the third
quarter of 2021 versus the previous year's third quarter.
During the third
quarter of 2021, sales at Mesoblast Ltd totalled
This is a drop of 86.2%
from the A$18.20 million in sales at the company during the third quarter in 2020.
During the first three quarters of 2021, sales totalled A$7.36 million, which is
than through the first three
quarters of 2020.
During the year ended June of 2020, sales at
Mesoblast Ltd were A$47.97 million (US$36.96 million).
increase of 105.0%
versus 2019, when the company's sales were A$23.40 million.
This was the third consecutive year of growth at Mesoblast Ltd.